(Q28194868)

6

0 references

Miles Dalby

object named as

Miles Dalby

5

0 references

Jean-Philippe Collet

1

object named as

Jean Philippe Collet

0 references

author name string

Erika Fine

3

0 references

Jean Louis Golmard

4

0 references

Annick Ankri

7

0 references

Raphaëlle Dumaine

8

0 references

Claude Lesty

9

0 references

Nicolas Vignolles

10

0 references

Daniel Thomas

Journal of the American College of Cardiology

11

0 references

language of work or name

English

0 references

publication date

1 January 2003

0 references

published in

0 references

volume

41

0 references

issue

1

0 references

page(s)

8-14

0 references

cites work

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

Enoxaparin in unstable angina patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

Low molecular weight heparin after mechanical heart valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota heart survey

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

Elderly Patients with Acute Coronary Syndromes: Higher Risk and Greater Benefit from Antithrombotic and Interventional Therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021

Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRIS

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902664-5

7 January 2021